A latent topic model for mining heterogenous non-randomly missing
  electronic health records data by Li, Yue & Kellis, Manolis
ar
X
iv
:1
81
1.
00
46
4v
1 
 [c
s.L
G]
  1
 N
ov
 20
18
A latent topic model for mining heterogenous
non-randomly missing electronic health records data
Yue Li Manolis Kellis
Computer Science and Artificial Intelligence Laboratory, MIT Cambridge, MA 02191
{liyue,manoli}@mit.edu
Abstract
Electronic health records (EHR) are rich heterogeneous collection of patient
health information, whose broad adoption provides great opportunities for sys-
tematic health data mining. However, heterogeneous EHR data types and biased
ascertainment impose computational challenges. Here, we present mixEHR, an
unsupervised generative model integrating collaborative filtering and latent topic
models, which jointly models the discrete distributions of data observation bias
and actual data using latent disease-topic distributions. We apply mixEHR on
12.8 million phenotypic observations from the MIMIC dataset, and use it to reveal
latent disease topics, interpret EHR results, impute missing data, and predict mor-
tality in intensive care units. Using both simulation and real data, we show that
mixEHR outperforms previous methods and reveals meaningful multi-disease in-
sights.
1 Introduction
With recent healthcare initiatives, many hospitals routinely generate large number of electronic
health records (EHR) data. In the United States, the number of non-federal acute care hospitals
with basic digital systems increased from 9.4 to 96% over the 7 year period between 2008 and
2015 [1–3]. Furthermore, the amount of comprehensive EHR data recording not only clinical notes
but also other data types increased from only 1.6% in 2008 to 40% in 2015 [3]. These data types
are largely standardized into systematic codes such as Logical Observation Identifiers Names and
Codes (LOINC) lab test codes, Diagnosis-Related Groups (DRG) code, International Classifica-
tion of Diseases (ICD)-9 code, and prescription for electronic drug information exchange code
(RxNorm). However, these raw EHR data present several challenges including interpretation of
high-dimensional, heterogeneous and extremely sparse clinical features, and extremely biased mea-
surements based on patient diagnoses and self-reported condition, formally known as non-missing
at random (NMAR) [4].
To address these challenges, we developed a Bayesian unsupervised learning approach that builds
on the concepts of collaborative filtering [5–9] and latent topic models [10–15]. While it is often
infeasible to directly model the joint distribution over the entire EHR feature space, it is possible to
formulate a latent topic model over discrete data. Each patient, hereby considered as a “document",
exhibits a mixture of “memberships" over a set of latent “disease topics" each prescribing a distinct
spectrum of disease frequency. In this paper, we present MixEHR for modeling heterogeneous EHR
data. MixEHR can simultaneously model an arbitrary number of EHR categories with separate
discrete distributions while jointly modeling the lab records and the lab results to account for the
NMAR observation biases. For efficient Bayesian learning, we develop a variational inference algo-
rithm that scales to large-scale patient EHR data. We apply MixEHR to the largest public dataset
called Medical Information Mart for Intensive Care (MIMIC)-III [1]. We first used MIMIC-III to
develop a simulation framework to evaluate MixEHR. We find that the clinical features emerging
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across EHR categories under common disease topics are biologically meaningful and reveal new
insights into disease comorbidity. We also find these disease topics to be highly predictive of mor-
tality.
2 Related work and our contributions
Our method is related to the widely popular text-mining method latent Dirichlet allocation (LDA)
[10]. However, LDA is not well suited to EHR phenotyping because (1) LDA assumes that the
clinical “terms" are completely observed in the patient “document", whereas as mentioned above
EHR data such as lab tests are often missing; (2) LDA is not suitable to jointly model heterogeneous
EHR data categories with distinct distributions; (3) even variations of LDA that deal with missing
data do not cope with NMAR mechanism. Our method is also related to several EHR phenotyping
studies focusing on matrix factorization and model interpretability [16–20]. These unsupervised
approaches differ from the recent supervised deep learning methods that primarily focus on predic-
tion performance of target clinical outcomes [21–27]. Several recent reviews are helpful in gaining
perspectives on the recent machine learning advancements in healthcare [28–30]. [18] proposed a
multi-view LDA with Gibbs sampling for a fixed set of data types. [31] proposed a single-view non-
probabilistic modeling of clinical notes, requiring predefined data to learn interpretable disease top-
ics. [32] jointly model multiple data matrices but require expert-curated tagging data. [33] proposed
a collective matrix factorization approach on multi-source EHR data. In contrast to these methods,
we jointly model lab tests and lab results while inferring missing lab results to account for NMAR
bias. Moreover, our joint collapsed variational Bayesian (CVB) inference algorithm provides fast
convergence to good local solutions compared to the Gibbs sampling in [18]. We extend CVB for
LDA only [13–15] by inferring the joint expectations of latent topics and lab results not only for
the observed but also missing lab tests, which enables us to account for the NMAR observation bias
common in the EHR data. We implemented MixEHR in C++ as a standalone Unix command-line
software using OpenMP for multi-threaded inference. It allows arbitrary number of discrete data
types and discrete states per EHR feature. On a 8-core Ubuntu server, MixEHR takes ∼2 hours to
learn 100 disease topics from 40,000 patient records over 50,000 EHR features across 6 data types.
3 MixEHR: a latent topic model for EHR data
We model EHR data using a generative latent topic model (Fig. 1). Suppose there are K latent
disease topics, each topic k ∈ {1, . . . ,K} under data type t ∈ {1, . . . , T } prescribes a vector
of unknown weights φ
(t)
k = [φ
(t)
wk]W (t) for W
(t) EHR features, which follows a Dirichlet distri-
bution with unknown hyperparameter βwt. Additionally, each topic is also characterized by a set
of unknown Dirichlet-distributed weights ηlk = [ηlkv ]Vl with Vl distinct values. For each patient
j ∈ {1, . . . , D}, the disease mixture membership θj is generated from theK-dimensional Dirichlet
θ
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Figure 1: Proposed MixEHR model.
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Figure 2: Averaged predictive log likelihood on
held-out patients in 5-fold cross-validation.
2
distributionDir(α) with unknown asymmetric hyperparameters αk. To generate EHR feature i for
patient j, a latent topic z
(t)
ij under data type t is first drawn from multinomial distribution with rate
θj . Given the latent topic z
(t)
ij , a clinical feature x
(t)
ij is drawn from multinomial distribution with
rate equal to φ
(t)
z
(t)
ij
.
For lab data, we use a generative process where each patient has a variable for the result for every
lab test regardless whether the results is observed. One important assumption we make here is
that the lab results ylj and lab observation rlj for patient j are conditionally independent given
the latent topic hlj , namely that the probability of taking the test and the value of that test both
depend on the true disease status, but not on each other. In terms of the generative process, we
first sample the latent variable hlj from the multinomial distribution with rate θj . Conditioned on
the latent variable, we then concurrently sample (1) the lab result ylj from Vl-dimensional Dirichlet
distribution ηlhlj with hyperparameters ζl over Vl values and (2) the lab observation indicator rlj
from Binomial distribution1 with rate ψlhij , which follows a Beta distribution with unknown shape
and scale hyperparameters al and bl. The hyperparameters αk, βwt, ζlv, al, bl’s follow unknown
Gamma distributions.
Formally, we first generate global variables for disease topics:
φ
(t)
k ∼ Dir(βt) :
Γ(
∑
w βwt)∏
w Γ(βwt)
∏
w
[φ
(t)
wk]
βwt−1
ηlk ∼ Dir(ζl) :
Γ(
∑
v ζlv)∏
v Γ(ζlv)
∏
v
ηζlv−1lkv , ψlk ∼ Bet(al, bl) :
Γ(al + bl)
Γ(al)Γ(bl)
ψal−1lk (1− ψlk)
bl−1
We then generate local variables for the binary EHR features of each patient:
θj ∼ Dir(α) :
Γ(
∑
k αk)∏
k Γ(αk)
∏
k
θαk−1jk ; zij ∼Mul(θj) :
∏
k
θ
[zij=k]
jk ;xij ∼Mul(φ
(t)
k ) :
∏
w
φ
[xij=w]
kw
and the local variables for the lab data including latent topic, lab result, and observation indicator:
hlj ∼Mul(θj) :
∏
k
θ
[hlj=k]
jk ; ylj ∼Mul(ηlhlj) :
∏
v
η
yljv
lhljv
; rlj ∼ Bin(ψlhlj ) : ψ
rlj
lhlj
(1− ψlhlj )
1−rlj
where Gam(.), Dir(.), Bet(.), Mul(.), and Bin(.) denote Gamma, Dirichlet, Beta, Multinomial,
and Binomial distributions, respectively. The notations are in Supplementary Information Table
1.
4 Variational Bayesian learning of MixEHR model
4.1 Marginalized likelihood integrating out θ,φ,ψ,η
Treating the latent variables as missing data, we can express the complete joint likelihood based on
our model as follows:
p(x, y, r, z, h, θ, φ, ψ, η|Θ) = p(θ|α)p(z, h|θ)p(x|z, φ)p(φ|β)p(r|h, ψ)p(y|h, η)p(η|ζ)p(ψ|a, b)
At this point, we could formulate a variational inference algorithm by optimizing an evidence lower
bound of the marginal likelihood with respect to the model parameters [34]. However, due to the re-
spective conjugacy of Dirichlet variables φ, η, θ to the multinomial likelihood variables x, y, {z, h},
and the conjugacy of Beta variable ψ to the binomial lab observation indicator variable r, we can
achieve better inference by first integrating out the Dirichlet and Beta variables and then inferring
1Binomial is used such that each lab tests can be performed multiple times on the same patient, which is not
uncommon in the real EHR data
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directly the distribution of the latent variables {z, h} as follows [14, 35]:
p(x, y, r, z, h|α, β, ζ, a, b) =
∫
p(z, h|θ)p(θ|α)dθ
∫
p(x|z, φ)p(φ|β)dφ∫
p(y|h, η)p(η|ζ)dη
∫
p(r|h, ψ)p(ψ|a, b)dψ
=
∏
j
Γ(
∑
k αk)∏
k Γ(αk)
∏
k Γ(αk + n
(.)
.jk +m.jk)
Γ(
∑
k αk + n
(.)
.jk +m.jk)
∏
k
∏
t
Γ(
∑
w βwt)∏
w Γ(βwt)
∏
w Γ(βt + n
(t)
w.k)
Γ(
∑
w βwt + n
(t)
w.k)∏
k
∏
l
Γ(
∑
v ζlv)∏
v Γ(ζlv)
∏
v Γ(ζlv +ml.kv)
Γ(
∑
v ζlv +ml.kv)
∏
k
∏
l
Γ(al + bl)
Γ(al)Γ(bl)
Γ(al + plk)Γ(bl + qlk)
Γ(al + plk + bl + qlk)
where the sufficient statistics are
n
(.)
.jk =
T∑
t=1
M
(t)
j∑
i=1
[z
(t)
ij = k], n
(t)
w.k =
D∑
j=1
M
(t)
j∑
i=1
[x
(t)
ij = w, z
(t)
ij = k] (1)
m.jk. =
L∑
l=1
Vl∑
v=1
yljv [hlj = k], ml.kv =
D∑
j=1
yljv[hlj = k] (2)
plk =
∑
j
[rlj = 1]
∏
v
yljv[hlj = k], qlk =
∑
j
[rlj = 0]
∑
v
[hlj = k, ylj = v] (3)
Note that we use yljv to denote the frequency of observing the lab test l of outcome v for patient j and
[ylj = v] as binary indicator of a single test. Detailed derivation is in Supplementary Information.
4.2 Joint collapsed variational Bayesian inference
The marginal likelihood can be approximated by evidence lower bound (ELBO):
log p(x, y, r|α, β, ζ, a, b) = log
∑
z,h
p(x, y, z, h|α, β, ζ, a, b)
q(z, h)
q(z, h) (4)
≥
∑
z,h
q(z, h) log p(x, y, z, h|α, β, ζ, a, b)−
∑
z,h
q(z, h) log q(z, h) (5)
= Eq(z,h)[log p(x, y, z, h|α, β, ζ, a, b)]− Eq(z,h)[log q(z, h)] ≡ LELBO (6)
Maximizing LELBO is equivalent to minimizing Kullback-Leibler (KL) divergence:
KL[q(z, h)||p(z, h|x, y, r)] = Eq(z,h)[log q(z, h)]− Eq(z,h)[log p(z, h, x, y)] + log p(x, y, r)
because log p(x, y, r) is constant and KL[q(z, h)||p(z, h|x, y, r)] + LELBO = log p(x, y, r).
Under mean-field factorization, the proposed distribution of latent variables z and h are defined as:
log q(z|γ) =
∑
t,i,j,k
[z
(t)
ij = k] log γ
(t)
ijk, log q(h|λ) =
∑
l,j,k
[hlj = k] logλljk (7)
Maximizing (6) with respect to the variational parameter γ
(t)
ijk and λljk is equivalent to calculating
the expectation of z
(t)
ijk and hljk with respect to all of the other latent variables [14, 36]:
log γ
(t)
ijk = Eq(z−(i,j))[log p(x, z)], logλljk = Eq(h−(l,j))[log p(y, r, h)] (8)
Normalizing the distribution of γ
(t)
ijk and λljk gives
γ
(t)
ijk =
exp(Eq(z−(i,j))[log p(x, z)])∑
k exp(Eq(z−(i,j))[log p(x, z)])
, λljk =
exp(Eq(h−(l,j))[log p(y, r, h)])∑
k exp(Eq(h−(l,j))[log p(y, r, h)])
(9)
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We can approximate these expectations by first deriving the conditional distribution for z
(t)
ijk and hljk
(Supplementary Information) and then approximating the sufficient statistics by the summation of
the variational parameters [14, 37]:
γ
(t)
ijk ∝
(
αk + n˜
−(i,j)
.jk + m˜.jk
) βtx(t)ij + [n˜
(t)
x
(t)
ij
.k
]−(i,j)∑
w βwt + [n˜
(t)
w.k]
−(i,j)

 (10)
To infer hlj = k, we will need to separately consider whether the lab test l is observed or missing.
In particular, we can infer the topic distribution of an observed lab test ylj at value v as:
λljkv ∝
(
αk + n˜.jk + m˜
−(l,j)
.jk
)( ζlv + m˜−(l,j,v)lkv∑
v′ ζlv′ + m˜
−(l,j,v)
lkv′
)(
al + p˜
−(l,j)
lk
al + p˜
−(l,j)
lk + bl + q˜lk
)
(11)
For unobserved lab tests, we infer the joint distribution of latent topic and lab result hlj = k, ylj = v:
piljkv ∝
(
αk + n˜.jk + m˜
−(l,j)
.jk
)( ζlv + m˜−(l,j,v)lkv∑
v′ ζlv′ + m˜
−(l,j,v)
lkv′
)(
bl + q˜
−(l,j)
lk
al + p˜lk + bl + q˜
−(l,j)
lk
)
(12)
where the notation n−(i,j) indicate the exclusion of variable index i, j and the sufficient statistics are
n˜
−(i,j)
.jk =
T∑
t=1
M
(t)
j∑
i′ 6=i
γi′jk, [n˜
(t)
x
(t)
ij
.k
]−(i,j) =
D∑
j′ 6=j
M
(t)
j′∑
i=1
[x
(t)
ij′ = x
(t)
ij ]γ
(t)
ij′k (13)
m˜
−(l,j)
.jk. =
L∑
l′ 6=l
Vl′∑
v=1
[rl′j = 1]yl′jvλl′jkv + [rl′j = 0]pil′jkv (14)
m˜
−(l,j,v)
l.kv =
D∑
j=1
L∑
l=1
Vl∑
v′ 6=v
[rlj = 1]yljv′λljkv′ + [rlj = 0]piljkv′ (15)
p˜
−(l,j)
lk =
∑
j′ 6=j
[rlj′ = 1]
∑
v
ylj′vλlj′k, q˜
−(l,j)
lk =
∑
j′ 6=j
[rlj′ = 0]
∑
v
piljkv (16)
Furthermore, we update the hyperparameters by maximizing the marginal likelihood under the
variational expectations via empirical Bayes fixed-point updates [37, 38]). For example, the up-
date for βwt is β
∗
wt ←
aβ−1+βwt
∑
k
∑
w
Ψ(βwt+n
(t)
w.k
)−KWtΨ(βwt)
bβ+
∑
k Ψ(Wtβwt+
∑
w n
(t)
w.k
−KΨ(Wtβwt)
. Other hyperparameters up-
dates are similar. The learning algorithm therefore follows expectation-maximization: E-step
infers γ
(t)
ijk, λljkv , piljkv’s; M-step updates model parameters. To learn MixEHR from massive-
scale EHR data in the future, we also developed a stochastic variational inference algorithm [39]
(Supplementary Information).
5 Experiments
5.1 MIMIC-III dataset
We applied MixEHR to MIMIC-III data [1], which contain ∼39,000 patients each with a single
admission and ∼7500 patients each with multiple admissions (Table 2 in Supplementary Informa-
tion). We used MixEHR to jointly model 6 data categories including unstructured text in clinical
notes, ICD-9, DRG, current procedural terminology (CPT), prescriptions, and lab tests, together
comprising of ∼53,000 clinical features and ∼12.8 million total clinical observations. For the 564
lab tests, we used the “flag" column in the MIMIC LABEVENT data file to record the lab results,
which contains empty value indicating normal results or “abnormal" or “delta". We set the results
of “delta" values to “abnormal" as they represent only a small fraction of the patients. As a result,
each lab test takes either normal or abnormal values. The lab tests that are not observed for each
patient are the missing lab tests. Notably, although we used only two-value system to represent the
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Figure 3: Predictive log likelihood of missing lab test results using four different MixEHR models.
lab results, MixEHR is able to handle arbitrary number of lab values. We trained and cross-validated
our model using the 39k single-admission records and evaluated the trained model using the earlier
admission of the 7500 test patients to predict mortality outcomes in their last admissions.
To evaluate model learning and monitor empirical convergence, we performed 5-fold cross-
validation. For each patient in the validation fold, we used randomly selected 50% of their EHR
features to infer their disease mixtures and then used the other 50% of the features to evaluate the
log predictive likelihood, which is a common metric to evaluate topic models [10, 15, 39]:∑
j
∑
t,i
log
∑
k
θˆjkφˆ
(t)
x
(t)
ij k
+
∑
l
[rlj = 1] log
∑
k
θˆjk(ψˆlk + ηˆlkylj ) (17)
where we inferred the variational expectations of the disease mixture and disease topics as:
θˆjk =
αk + n˜
(.)
jk∑
k′ αk′ + n˜
(.)
jk′
, φˆ
(t)
wk =
βwt + n˜
(t)
wk∑
w′ βw′t + n˜
(t)
w′k
, ψˆlk =
al + p˜lk
al + p˜lk + bl + q˜lk
, ηˆlkv =
ζlv + m˜lkv∑Vl
v′=1 ζlv′ + m˜lkv′
Sensible models should demonstrate improved predictive likelihood on the held-out patients. We
evaluated the predictive log likelihood of models with K ∈ {10, 25, 40, 50, 60, 75, 100, 125, 150}
and set K=75 as it gave the highest predictive likelihood (Fig. 2).
5.2 Simulation to evaluate robustness to non-randomly missing lab tests
To evaluate the novel NMAR aspect of MixEHR, we needed to know the underlying results of the
truly missing lab tests for each patient, which is obviously not available. To this end, we simulated
EHR data from the presented generative model. Specifically, we ran MixEHR on the full MIMIC
data until convergence with the topic number set to 75. We then used the patients’ mixtures and
the trained model parameters to generate lab data and the other 5 EHR data types. In particular,
multinomial latent variable assignments for each EHR variable and each patient were sampled from
the given patient mixtures, which were shared across all EHR variables. The missing indicators
of each lab test on each patient were simulated from a binomial distribution with the trained beta
parameters specific to the latent variable assignments.
We performed 5-fold cross-validation using the simulated data. Because NMAR is only relevant
to the lab data, we focused on evaluating the predictive log likelihood on the missing lab test (i.e.,∑
l,j [rlj = 1] log
∑
k θˆjk(ψˆlk + ηˆlkylj ). Specifically, we used the observed data to infer the mixture
of the held-out patients and then used the inferred patient mixtures and the model parameters to
impute the missing lab tests. Because the predictive log likelihood is the product of the normalized
mixtures and normalized imputed lab results, it is independent from the model complexity and
therefore an appropriate evaluation metric. As comparisons, we evaluated four different variations of
the model: (1) MixEHR_nmar modeling NMAR using lab view only (labview); (2) MixEHR_nmar
using all EHR (mixview); (3) & (4) MixEHR_mar assuming the lab results are missing at random
(MAR) using lab (labview) and all EHR (mixview), respectively. For the MAR model, we did not
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Figure 4: Top five EHR features and lab tests for select topics from a 75-topic MixEHR model.
estimate the distribution of the missing indicator and we only used the observed lab results to update
the models as opposed to using both the observed and expected missing lab results.
While the training likelihoods increased in all models, only the NMAR models achieved increasing
averaged predictive log likelihood on the missing lab tests for the held-out patients (Fig. 3). More-
over, integrating both lab tests and auxiliary EHR data (i.e., clinical notes, ICD-9, prescriptions, etc)
provided further improvements. Therefore, our model is robust to NMAR lab results.
5.3 Multi-view disease topics reveal meaningful pathology
We examined the clinical relevance of the learned disease topics (i.e., φ, ψ, η) by taking the top
5 EHR binary features and the top 5 lab tests from the same topics. Taking a common index k
from those 3 topic matrices gives us one “disease topic" distribution over the clinical terms across
categories. Here we represented the disease topics over lab data using an empirical score calculated
as the abnormal lab results weighted by the observation bias normalized over all lab tests for the
same topics: ψlkηlkv/
∑
l′ ψl′kηl′kv . Here we sought to intuitively examine how diversified and
distinct the disease topics were and how they might help interpreting abnormal lab results.
For demonstration purpose, we took disease topics that exhibit the highest probabilities over a broad
range of diseases including ICD-9 with prefixes {250, 296, 331, 042, 205, 415, 571}, which repre-
sent diabetes, psychoses, neurodegeneration,HIV, myeloid leukemia, acute pulmonary heart disease,
chronic liver disease and cirrhosis, respectively. Notably, these ICD-9 codes are not necessarily the
highest ranked features for each topic but we expected prominent enrichments of related clinical
terms. Indeed, we observed salient contrast of each topic in terms of the top representative EHR
features across diverse EHR categories (colored bars on the right; Fig. 4a). Notably, if we were
to model the data without modeling distinct distributions over each data category using LDA, the
disease topics would have been dominated by clinical notes as they contain overwhelmingly larger
number of features (i.e., words) than the other categories. Moreover, we observed interesting con-
nections between abnormal lab results and specific diseases. For instance, topic M31 is enriched for
alcohol cirrhosis and blood tests in ascites typical for cirrhosis patients; pulmonary embolism that
manifests as blood clotting in lung is linked with proliferation of blood cells via topics M35; under
M42, HIV is related with abnormal counts of immune cells such as CD4/CD8 and lymphocytes; dia-
betes tends to rank high with acetone level under M48, and psychoses topic M62 enriched for opioid
abuse is associated with valproic acid and lithium (known markers for psychiatry). Interestingly,
topic M59 associated with neurodegenerative diseases such as Alzheimer’s disease (AD) is strongly
associated with vitamin B12, which was shown to exhibit differential pattern in AD patients [40].
5.4 Mortality predictions
Predicting patients’ mortality risks in Intensive Care Unit (ICU) is vital to assessing the severity of
illness or trauma and facilitating subsequent urgent care. Because we were able to distill meaningful
disease topics from heterogeneous EHR data, we sought to assess the predictive power of these
disease topics for mortality predictions. For each patient, we labelled them as “deceased" if their
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b. prospective mortality prediction
0%
25%
50%
75%
100%
0% 25% 50% 75% 100%
False positive rate
T
ru
e
 p
o
s
it
iv
e
 r
a
te
mixehr_K50 (85%)
mixehr_K75 (79.8%)
LDA_K50 (75.9%)
LDA_K75 (74.6%)
0%
25%
50%
75%
100%
0% 25% 50% 75% 100%
Recall
P
re
c
is
io
n mixehr_K50 (31.2%)
mixehr_K75 (21.3%)
LDA_K50 (22.9%)
LDA_K75 (20.8%)
c. mortality-related meta-phenotypes
a. Mortality predictions by 5-fold CV
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Figure 5: Mortality prediction. a. Five-fold cross-validation on predicting mortality of patients with
single-admission. b. Predicting patients’ mortality outcomes in the last admission using mixture
embedding of EHR early admission. c. Topic clinical features of the most and least predictive
topics.
death times were recorded in the admission data. Out of the ∼39000 patients with single admission,
4351 (11%) were deceased. We experimented with K=50 and 75 topics. As baseline, we also
evaluated LDA implemented in R package “topicmodels" [41] on flattened EHR matrix of all 6 data
types.
We first performed a 5-fold cross-validation (CV) on patients with single admission by stratifying
the patients into five folds with equal proportion of alive and deceased patients. For each CV round,
we trained MixEHR on four folds to learn the disease mixture topics. We then applied the trained
model to infer the disease mixtures of the training folds, which were then used as predictors to
train the supervised LASSO regression on mortality response variable. Finally, we used the trained
LASSO to predict the mortality of the validation fold and repeated the same process for the five
folds. Note: (1) mortality labels were not used in learning the disease topics; (2) the unsupervised
model were not trained on the test folds. For all CV folds, we recorded the predictions and mortality
labels to generate the ROC and precision-recall curves (PRC) and evaluated the area under these
curves (AUC). With 75 (50) topics, we obtained 92% (90.9%) AUROC and 63% (59.7%) AUPRC
whereas LDA obtained only 85% (83%) AUROC and 51% (45.2%) AUPRC (Fig. 5a; Table 1).
Moreover, we also performed evaluation on the 7500 patients with multiple admissions. We first
trained MixEHR or LDA and LASSO models on the full training set of 39,000 single-admission
records. We then inferred the disease mixtures of the test patients from their EHR data in the
earliest admission only, predicted mortality outcomes of the patients, and compared the predictions
with the death labels in their last admissions. We used only the patients whose last admission was
after 30 days but within 6 months of their first admissions, which gave us 458 deceased and 6079
alive patients (7% positive labels). With 75 (50) topics, we obtained 79.8% (85%) AUROC and
21.3% (31.2%) AUPRC compared favorably to LDA (Fig. 5b; Table 1). Based on the LASSO
linear coefficients, the top 3 most predictive disease topics associated with mortality are enriched for
cardiac arrest, acute liver failure, and septicemia, whereas the least predictive topic is related with
newborn (Fig. 5c).
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Table 1: Mortality prediction
Data Method AUROC AUPRC
K=50 K=75 K=50 K=75
5-fold CV LDA 83.0 85.5 45.2 50.9
5-fold CV MixEHR 90.9 92.1 59.7 63.4
Prospective LDA 75.9 74.6 22.9 20.8
Prospective MixEHR 85 79.8 31.2 21.3
6 Conclusion and Future Work
In this paper, we present MixEHR to jointly model heterogeneous EHR data while accounting for
NMAR. Our approach demonstrates robustness to NMAR lab results and the ability to distill mean-
ingful disease topics, linking lab results to other EHR features across categories. We also achieved
promising mortality predictions. We expect that our method will have broad applications in health-
care. We only demonstratedMixEHR on ICU EHR due to data availability but expect it to also work
well on out-patient data. As an extension of MixEHR, we will incorporate longitudinal aspects of
the EHR data to model disease progressions (e.g., [42, 43]).
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